Literature DB >> 17596363

Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.

Yu-Tsung Huang1, Chien-Ching Hung, Chun-Hsing Liao, Hsin-Yun Sun, Shan-Chwen Chang, Yee-Chun Chen.   

Abstract

Galactomannan (GM) is a heteropolysaccharide in the cell walls of most Aspergillus and Penicillium species. Cross-reactivity of Cryptococcus neoformans galactoxylomannan in an Aspergillus GM test has also been reported. In this study, we used a Platelia Aspergillus enzyme immunoassay kit (Bio-Rad) to test serum samples obtained from 48 human immunodeficiency virus (HIV)-infected patients (15 with penicilliosis [7 with fungemia alone, 4 with cavitary lung lesions alone, 3 with both fungemia and cavitary lung lesions, and 1 with disseminated disease], 22 with cryptococcosis [11 with fungemia alone, 5 with cavitary lung lesions, 3 with both, and 3 with meningitis alone], and 11 without any invasive fungal infection [control]) for GM levels. None of the patients had aspergillosis or concurrent use of piperacillin-tazobactam or amoxicillin-clavulanate. The median time between diagnosis of fungal infection and collection of serum samples was 0 days for penicilliosis and 1.5 days for cryptococcosis. Of patients with penicilliosis, cryptococcosis, and controls, 73.3%, 13.6%, and 9%, respectively, had GM optical density (OD) indices of >0.5 (P = 0.0001). GM OD indices were higher for penicilliosis (median OD index, 4.419; range, 0.158 to >20) than for cryptococcosis (median, 0.247; range, 0.112 to 3.849) cases (P < 0.001). Patients with fungemic penicilliosis had higher OD indices (median, 10.628; range, 0.401 to >20) than patients with nonfungemic penicilliosis (median, 0.378; range, 0.158 to 4.419) and patients with cryptococcemia (median, 0.231; range, 0.112 to 1.168) (P < 0.001). Of the 15 patients with cavitary lung lesions, those with penicilliosis had higher antigen levels (median OD index, 1.641; range, 0.247 to >20) than those with cryptococcosis (median, 0.227; range, 0.112 to 3.849) (P = 0.011). This study showed that the GM OD index was significantly elevated for HIV patients with penicilliosis. The use of the GM antigen assay may facilitate earlier diagnosis of Penicillium marneffei infection for HIV-infected patients in areas of endemicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596363      PMCID: PMC2045252          DOI: 10.1128/JCM.00050-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Penicillium marneffei fungaemia in an allogeneic bone marrow transplant recipient.

Authors:  P C Y Woo; S K P Lau; C C Y Lau; K T K Chong; W T Hui; S S Y Wong; K Y Yuen
Journal:  Bone Marrow Transplant       Date:  2005-04       Impact factor: 5.483

2.  1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.

Authors:  Monique A S H Mennink-Kersten; Adilia Warris; Paul E Verweij
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

3.  Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy.

Authors:  Hsin-Yun Sun; Mao-Yuan Chen; Szu-Min Hsieh; Wang-Huei Sheng; Sui-Yuan Chang; Chin-Fu Hsiao; Chien-Ching Hung; Shan-Chwen Chang
Journal:  Jpn J Infect Dis       Date:  2006-10       Impact factor: 1.362

Review 4.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

6.  Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus.

Authors:  J P Latgé; H Kobayashi; J P Debeaupuis; M Diaquin; J Sarfati; J M Wieruszeski; E Parra; J P Bouchara; B Fournet
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 8.  Disseminated histoplasmosis in persons infected with human immunodeficiency virus.

Authors:  R A Hajjeh
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

9.  Disseminated Penicillium marneffei infection in southeast Asia.

Authors:  K Supparatpinyo; C Khamwan; V Baosoung; K E Nelson; T Sirisanthana
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

10.  Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy.

Authors:  H-Y Sun; M-Y Chen; C-F Hsiao; S-M Hsieh; C-C Hung; S-C Chang
Journal:  Clin Microbiol Infect       Date:  2006-04       Impact factor: 8.067

View more
  25 in total

1.  Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.

Authors:  R S Ying; T Le; W P Cai; Y R Li; C B Luo; Y Cao; C Y Wen; S G Wang; X Ou; W S Chen; S Z Chen; P L Guo; M Chen; Y Guo; X P Tang; L H Li
Journal:  HIV Med       Date:  2020-12       Impact factor: 3.180

2.  Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Authors:  M Aigner; M Wanner; P Kreidl; C Lass-Flörl; M Lackner
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Case Report: Disseminated Talaromyces (Penicillium) marneffei and Mycobacterium tuberculosis Coinfection in a Japanese Patient with Acquired Immunodeficiency Syndrome.

Authors:  Shuji Hatakeyama; Takeshi Yamashita; Toshiyasu Sakai; Katsuhiko Kamei
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

4.  Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.

Authors:  Melissa O Xavier; Alessandro C Pasqualotto; Isabel Cristina E Cardoso; Luiz Carlos Severo
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

Review 5.  State of the art diagnostic of mold diseases: a practical guide for clinicians.

Authors:  F Beirão; R Araujo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-18       Impact factor: 3.267

6.  Early-Onset Invasive Infection Due to Corynespora cassiicola Associated with Compound Heterozygous CARD9 Mutations in a Colombian Patient.

Authors:  Carlos A Arango-Franco; Marcela Moncada-Vélez; Claudia Patricia Beltrán; Indira Berrío; Cristian Mogollón; Andrea Restrepo; Mónica Trujillo; Sara Daniela Osorio; Lorena Castro; Lina Vanessa Gómez; Ana María Muñoz; Verónica Molina; Delsy Yurledy Del Río Cobaleda; Ana Cristina Ruiz; Carlos Garcés; Juan Fernando Alzate; Felipe Cabarcas; Julio Cesar Orrego; Jean-Laurent Casanova; Jacinta Bustamante; Anne Puel; Andrés Augusto Arias; José Luis Franco
Journal:  J Clin Immunol       Date:  2018-09-28       Impact factor: 8.317

Review 7.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

8.  Evaluation of a Novel Aspergillus Antigen Enzyme-Linked Immunosorbent Assay.

Authors:  Karl Dichtl; Ulrich Seybold; Steffen Ormanns; Heidi Horns; Johannes Wagener
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

Review 9.  Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.

Authors:  L J Wheat; T J Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

Review 10.  Fungal diagnostics.

Authors:  Thomas R Kozel; Brian Wickes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.